CD8A and neoplasm: Considering the evident correlation between the CD8+ T cell-associated risk score and diverse immune checkpoints, we subsequently devoted to figuring out whether the risk score correlated with the tumor immune exclusion score, which was recognized as one of immunotherapy predictors [22].